MiR-150 alleviates neuropathic pain via inhibiting toll-like receptor 5

Li-Juan Ji1, Jing Shi2, Jing-Min Lu3

  • 1Department of Sport Medicine and Rehabilitation Center, School of Kinesiology, Shanghai University of Sport, Shanghai, China.

Insights

MicroRNA-150 (miR-150) alleviates neuropathic pain by reducing inflammation. It targets Toll-like receptor 5 (TLR5), suggesting miR-150 as a potential therapeutic target for pain management.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • MicroRNAs (miRNAs) play roles in neuropathic pain, but mechanisms remain unclear.
  • Neuropathic pain, often resulting from nerve injury, involves complex inflammatory processes.

Purpose of the Study:

  • To investigate the role of miR-150 in neuropathic pain.
  • To explore the regulatory mechanism of miR-150 in chronic sciatic nerve injury (CCI) rat models.

Main Methods:

  • Established a rat model of neuropathic pain via chronic sciatic nerve injury (CCI).
  • Overexpressed miR-150 and assessed its effects on pain behaviors and inflammatory markers (COX-2, IL-6, TNF-α).
  • Utilized bioinformatic analysis to identify miR-150 targets, predicting Toll-like receptor 5 (TLR5).
  • Validated the interaction between miR-150 and TLR5 in vitro and in vivo.
  • Investigated the effect of TLR5 manipulation on miR-150 expression and pain.

Main Results:

  • Overexpression of miR-150 significantly reduced neuropathic pain and inflammatory cytokine levels in CCI rats.
  • Bioinformatic analysis identified TLR5 as a target of miR-150.
  • miR-150 overexpression suppressed TLR5 expression, while TLR5 upregulation decreased miR-150 levels.
  • Overexpression of TLR5 reversed the pain-alleviating effects of miR-150.

Conclusions:

  • miR-150 inhibits neuropathic pain development in CCI rats by suppressing TLR5-mediated neuroinflammation.
  • miR-150 represents a potential novel therapeutic target for neuropathic pain treatment.